Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 28,410 shares at $90.04 ($2.6M) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Scheduled sale ($2.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.04 | 14,205 | $1.3M | 50.0% |
| 2 | $90.04 | 14,205 | $1.3M | 50.0% |
| Total | $90.04 avg | 28,410 | $2.6M | 100% |
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-15 | $1.8M | — | Filing → |